NCT00303810 Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma Status COMPLETED Phase NA
NCT00293423 GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma Status COMPLETED Phase PHASE1/PHASE2
NCT00293358 Combination Chemotherapy and Radiation Therapy in Treating Patients With Germ Cell Tumors in the Brain Status COMPLETED Phase PHASE3
NCT00287924 High-Dose Methotrexate in Treating Young Patients With Residual Ependymoma Status UNKNOWN Phase PHASE2
NCT00281905 Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors Status UNKNOWN Phase PHASE2
NCT00278278 Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas Status UNKNOWN Phase PHASE3
NCT00278252 Etoposide in Treating Young Patients With Relapsed Ependymoma Status UNKNOWN Phase PHASE2
NCT00278239 Quality of Life in Patients Who Have Undergone Previous Treatment for Primitive Neuroectodermal Tumors Status UNKNOWN Phase N/A
NCT00276783 Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases Status UNKNOWN Phase PHASE2
NCT00276770 Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas Status COMPLETED Phase NA
NCT00276718 Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell Tumors Status UNKNOWN Phase NA
NCT00276666 Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Metastatic Medulloblastoma Who Have Undergone Surgery Status UNKNOWN Phase PHASE2
NCT00275067 Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery Status UNKNOWN Phase PHASE1/PHASE2
NCT00275002 O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem Tumors Status COMPLETED Phase PHASE2
NCT00274911 Radiation Therapy Followed By Combination Chemotherapy in Treating Young Patients With Supratentorial Primitive Neuroectodermal Tumors Status UNKNOWN Phase PHASE2
NCT00274755 Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas Status COMPLETED Phase PHASE2
NCT00268359 Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas Status COMPLETED Phase PHASE2
NCT00258453 Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma Status COMPLETED Phase NA
NCT00255671 Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders Status COMPLETED Phase N/A
NCT00253721 Melphalan With BBBD in Treating Patients With Brain Malignancies Status TERMINATED Phase PHASE1